Rhino Biotech Limited (RBRXF) Research

Rhino Biotech Limited is dedicated to pioneering the development of health supplements sourced from plants and fungi, in addition to biopharmaceutical solutions designed for both disease prevention and treatment. The company adopted its current name, Rhino Biotech Limited, in September 2021, having previously operated as Eurasia Energy Limited. Established in 2003, its operations are based in South Hill, Anguilla.

Market snapshot

Symbol
RBRXF
Price
$0.00
Day change
+9900.00%
Market cap
$3.1K
P/E ratio
-0.16x
52-week range
0.000001-0.0001
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Atlas Financial Holdings, Inc. (AFHIF)
  • Amanasu Techno Holdings Corporation (ANSU)
  • ConectiSys Corporation (CONC)
  • Excellerant, Inc. (EXCL)
  • Laredo Resources Corp. (LRDR)
  • Palayan Resources, Inc. (PLYN)
  • SMSA Crane Acquisition Corp. (SSCR)
  • Tal-Cap, Inc. (TALC)

Open Rhino Biotech Limited (RBRXF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.